Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.


Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 27 01 2018
accepted: 13 06 2018
pubmed: 24 6 2018
medline: 21 3 2019
entrez: 24 6 2018
Statut: ppublish

Résumé

22q11.2 deletion syndrome (22q11.2DS) is the most common known microdeletion in humans occurring in 1 out of 2000-4000 live births, with increasing numbers of individuals with the microdeletion living into adulthood. The aim of the study was to explore the education and employment trajectories of individuals with 22q11.2DS from childhood to adulthood in a large cohort composed of two significant samples. 260 individuals with 22q11.2DS, 134 male and 126 female, aged 5-59 years (mean age 21.3 ± 10.8 years) were evaluated at two sites, Geneva (GVA) and Tel Aviv (TA). Psychiatric comorbidities, IQ score, and adaptive functioning were assessed using gold-standard diagnostic tools. Demographic factors, such as data about education, employment, marital status, and living status, were collected. Children entering elementary school (5-12 years) were significantly more likely to attend a mainstream school, while adolescents were significantly more likely to attend special education schools (p < 0.005). Cognitive abilities, and not adaptive functioning, predicted school placement. Among adults with 22q11.2DS (n = 138), 57 (41.3%) were unemployed, 46 (33.3%) were employed in open market employment, and 35 (25.4%) worked in assisted employment. In adulthood, adaptive functioning more than cognitive abilities predicted employment. Surprisingly, psychotic spectrum disorders were not found to be associated with employment. Individuals with 22q11.2DS are characterized by heterogeneity in educational and employment profiles. We found that cognitive abilities and adaptive functioning, and not the presence of psychiatric disorders, are key factors in school placement and employment. These factors should, therefore, be taken into account when planning optimal development of individuals with 22q11.2DS.

Identifiants

pubmed: 29934817
doi: 10.1007/s00787-018-1184-2
pii: 10.1007/s00787-018-1184-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

31-42

Références

J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Eur J Med Genet. 2014 Mar;57(4):157-62
pubmed: 24576609
J Dev Behav Pediatr. 2012 Nov-Dec;33(9):713-20
pubmed: 23117596
J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1060-1068
pubmed: 19797984
Genet Med. 2015 Aug;17(8):599-609
pubmed: 25569435
Am J Med Genet B Neuropsychiatr Genet. 2015 Dec;168(8):730-8
pubmed: 26400629
Eur J Pediatr. 2010 Aug;169(8):983-9
pubmed: 20186429
Dev Disabil Res Rev. 2008;14(1):3-10
pubmed: 18636631
J Intellect Disabil Res. 2009 Apr;53(4):303-18
pubmed: 19087215
Schizophr Res. 2006 Oct;87(1-3):270-8
pubmed: 16753283
Prenat Diagn. 2015 Aug;35(8):801-9
pubmed: 25962607
JAMA Psychiatry. 2015 Apr;72(4):377-85
pubmed: 25715178
Genet Med. 2012 Oct;14(10):836-43
pubmed: 22744446
BMC Med Genet. 2012 Dec 17;13:122
pubmed: 23245648
Schizophr Res. 2017 Apr;182:120-128
pubmed: 27667369
Br J Psychiatry. 2012 Jun;200(6):462-8
pubmed: 22661678
Psychiatry Res. 2017 Jul;253:99-106
pubmed: 28364592
J Am Acad Child Adolesc Psychiatry. 2000 Jan;39(1):59-66
pubmed: 10638068
Am J Med Genet A. 2008 Sep 15;146A(18):2355-60
pubmed: 18698620
Am J Med Genet A. 2018 Nov;176(11):2365-2374
pubmed: 29171699
Eur Child Adolesc Psychiatry. 2017 Nov;26(11):1283-1307
pubmed: 28429134
Res Dev Disabil. 2013 Sep;34(9):2937-45
pubmed: 23816629
Am J Psychiatry. 2014 Jun;171(6):627-39
pubmed: 24577245
Genet Med. 2001 Jan-Feb;3(1):23-9
pubmed: 11339373
Psychol Med. 2014 Apr;44(6):1267-77
pubmed: 24016317
J Dev Behav Pediatr. 2015 Oct;36(8):639-50
pubmed: 26372046
Psychiatry Res. 2012 Apr 30;196(2-3):277-84
pubmed: 22377578
J Child Adolesc Psychopharmacol. 2003 Spring;13(1):29-40
pubmed: 12804124
Nat Neurosci. 2005 Nov;8(11):1500-2
pubmed: 16234808
Am J Ment Retard. 2001 Mar;106(2):162-72
pubmed: 11321607

Auteurs

Mariela Mosheva (M)

The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 5262000, Tel Hashomer, Israel. marymoshev@gmail.com.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. marymoshev@gmail.com.

Virginie Pouillard (V)

Developmental Imaging and Psychopathology Lab, Department of Psychiatry, School of Medicine, University of Geneva, Geneva, Switzerland.

Yael Fishman (Y)

The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 5262000, Tel Hashomer, Israel.

Lydia Dubourg (L)

Developmental Imaging and Psychopathology Lab, Department of Psychiatry, School of Medicine, University of Geneva, Geneva, Switzerland.

Dafna Sofrin-Frumer (D)

The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 5262000, Tel Hashomer, Israel.

Yaffa Serur (Y)

The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 5262000, Tel Hashomer, Israel.

Abraham Weizman (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Geha Mental Health Center and Felsenstein Medical Research Center, Petah Tikva, Israel.

Stephan Eliez (S)

Developmental Imaging and Psychopathology Lab, Department of Psychiatry, School of Medicine, University of Geneva, Geneva, Switzerland.
Department of Genetic Medicine and Development, School of Medicine, University of Geneva, Geneva, Switzerland.

Doron Gothelf (D)

The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 5262000, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

Maude Schneider (M)

Developmental Imaging and Psychopathology Lab, Department of Psychiatry, School of Medicine, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH